SHORT BIO
Dan Gorenstein is the former senior reporter for Marketplace’s Health Desk, covering the business of healthcare.
Prior to Marketplace, Dan spent more than 11 years at New Hampshire Public Radio. He got his start in journalism at the Chicago Reporter, an investigative journal that examines race and class disparities in the Chicago area. He’s won numerous national and local awards, including the Society of Professional Journalist Sigma Delta Chi investigative reporting award.
Latest Stories (640)
How much is the DSM-5 worth?
May 17, 2013
The diagnostic mental health bible comes out this weekend and as doctors' manuals go, it's high profile and big money.
Will dollars follow the stem cell breakthrough?
May 16, 2013
Researchers have figured out how to clone human embryonic stems cells, which can be used to develop tissue for many uses. Will investors jump in?
The Obamacare charm offensive begins
May 10, 2013
The Affordable Care Act's PR push is gearing up for prime time.
U.S. releases data showing striking differences in hospital prices
May 8, 2013
The public can search a database for prices for 100 common procedures at every hospital in the country, opening a window onto price differences.
What's behind the slow rise of health care costs? Our pocketbooks
May 7, 2013
Health care costs have been rising at a slower rate for the last four years. Why? Hint: The answer is not the recession.
Pfizer wants you to buy Viagra online -- from Pfizer
May 6, 2013
Viagra is one of the most-counterfeited drugs on the web, and Pfizer's latest effort to tackle that issue is a first.
Will you buy into Obamacare or pay the penalty?
Apr 30, 2013
The new health care law requires individuals to carry health insurance beginning next year, or pay a small fine. Behavioral economists say even a little punishment may go a long way to get people to sign up.
Being a leader in the midst of chaos: How one Boston business is coping the day after
Apr 16, 2013
The day after bombings at the Boston Marathon, one business is concentrated on what matters — their employees.
OxyContin's waiting game: Generic drug makers salivate while the FDA wants safer pills
Apr 16, 2013
OxyContin is supposed to come off patent and generic drug makers are excited. But, the FDA may put a stop to it all to wait for safer pills.
DNA sequencing celebrates its first decade
Apr 12, 2013
The anniversary brings with it a new and lucrative era of personalized medicine.